Finance

Beta
Lists
000972:SHE
Chalkis Health Industry Co Ltd
CN¥3.55
+0.57%
(+0.020) 1D
Jun 5, 3:04:45 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000972...
Open
CN¥3.52
High
CN¥3.56
Low
CN¥3.48
Mkt. cap
2.74B
Avg. vol.
9.39M
Volume
5.94M
52-wk high
CN¥5.17
52-wk low
CN¥2.90
EPS
-CN¥0.08
Shares outstanding
771.28M
No. of employees
367
Open
CN¥3.52
High
CN¥3.56
Low
CN¥3.48
Mkt. cap
2.74B
Avg. vol.
9.39M
Volume
5.94M
52-wk high
CN¥5.17
52-wk low
CN¥2.90
EPS
-CN¥0.08
Shares outstanding
771.28M
No. of employees
367
News stories
From sources across the web
Profile
Xinjiang Chalkis Company Ltd is a major Chinese agricultural company that processes tomatoes and fruits, founded in 1994. It also produces conical barrels and wooden ton-boxes. It is headquartered in Urumqi, Xinjiang, China. Xinjiang Chalkis is an export-oriented state-owned enterprise that is supported and developed by the Xinjiang Production and Construction Corps, affiliated to the 6th division. It was established in May 2000 with a registered capital of 371.7 million yuan. The production facilities are mainly located in Xinjiang, Inner Mongolia and Tianjin. By the end of 2005, the company had total assets worth 2.137 billion yuan and an annual sales revenue of more than 700 million yuan. Over 95% of the company's products are exported to the international market. Since 2004, its products constitute 18% of the world's tomato sauce trading volume. Its small-can tomato sauce products account for 60% of the African market share. Since 2009, the company has heavily invested in tomato harvesting mechanization, and harvesting machine leasing is a minor revenue line. Wikipedia
About Chalkis Health Industry Co Ltd
CEO-
Employees367
FoundedJun 30, 1994
Headquarters-
SectorFood
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
166.24M
109.24M
137.94M
54.82M
Cost of goods sold
189.36M
124.90M
291.69M
53.92M
Cost of revenue
189.36M
124.90M
291.69M
53.92M
Research and development expenses
655.28K
505.54K
-619.80K
150.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.73M
24.68M
27.17M
13.15M
Operating expense
38.19M
25.07M
23.85M
12.75M
Total operating expenses
227.55M
149.96M
315.55M
66.67M
Operating income
-61.31M
-40.73M
-177.60M
-11.85M
Other non operating income
-21.00K
-309.88K
280.17K
-598.81K
EBT including unusual items
-68.70M
-73.12M
96.53M
-20.27M
EBT excluding unusual items
-72.70M
-50.82M
-190.45M
-21.14M
Income tax expense
657.19K
720.07K
1.58M
108.79K
Effective tax rate
-0.96%
-0.98%
1.63%
-0.54%
Other operating expenses
1.68M
159.58K
3.08M
36.00K
Net income
-67.45M
-69.38M
97.86M
-19.63M
Net profit margin
-40.57%
-63.52%
70.94%
-35.81%
Earnings per share
-
-
-
-
Interest and investment income
71.96K
10.89K
168.13K
134.44K
Interest expense
-11.32M
-9.92M
-12.53M
-8.83M
Net interest expenses
-11.25M
-9.91M
-12.37M
-8.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
-51.73M
-31.61M
-168.27M
-2.52M
Gain or loss from assets sale
-2.41M
2.41M
-3.39M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more